CDP791

Therapeutic focus

Non-Small-Cell Lung Cancer

Type of molecule

NBE (Two Fab' fragments chemically linked and PEGylated)

Mode of action

Angiogenesis inhibitor that prevents the growth of new blood vessels, thereby affecting tumour growth. It binds to and blocks signaling through VEGF receptor 2 (VEGFR-2 or KDR)